Detalhe da pesquisa
1.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol
; 64(1): 19-28, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321288
2.
THE PERFORMANCE OF A RAPID TEST FOR ANTI-HCV SCREENING IN ORAL FLUIDS.
Roum Arch Microbiol Immunol
; 74(1-2): 40-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26727853
3.
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report.
BMC Gastroenterol
; 11: 30, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21453456
4.
Body Composition Changes in Patients with Chronic Hepatitis C.
J Gastrointestin Liver Dis
; 25(3): 323-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27689196
5.
Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
Antivir Ther
; 19(3): 235-43, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23574686
6.
Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
Antivir Ther
; 19(3): 245-57, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24343051
7.
Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
J Gastrointestin Liver Dis
; 22(1): 101-4, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23539399